January 2, 2024

Palliative care is underused for patients with malignant urinary obstruction

Less than half of patients with malignant ureteral obstruction (MUO) – a serious complication of advanced cancer, with a poor prognosis – receive palliative care (PC) for their condition, reports a paper in the January issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer. Hospice care can promote patient comfort while […]

admin Health 0 3 min read
January 2, 2024

Silent Epidemic: Japan’s Rising Over-the-Counter Drug Abuse Sparks Urgent Call for Awareness

A non-prescription drug abuse crisis in Japan seems only one overdose away. The demand for a particular anti-cough drug has been rising, along with the social impact of its abuse due to its psychosomatic effects. The ease of obtaining information online about how to acquire over-the-counter medications or OTCs for achieving overdose, however, does not appear to be the real […]

admin Health 0 2 min read
January 2, 2024

FDA updates LDL-C lowering indication for Nexletol (bempedoic acid) tablet and Nexlizet (bempedoic acid and ezetimibe) tablet – Esperion

Esperion announced that the FDA has approved an updated LDL-cholesterol lowering indication for Nexletol and Nexlizet to include the treatment of primary hyperlipidemia as a qualifier for existing approved populations . Additionally, the maximally tolerated qualifier for statin use has been removed, and the prior limitation of use stating “the effect of Nexlizet or Nexletol on cardiovascular morbidity and mortality […]

admin Health 0 1 min read
December 31, 2023

FDA grants expanded approval to wilate as the first VWF concentrate for prophylaxis in all types of von Willebrand disease – Octapharma

Octapharma USA announced the expansion of the FDA approval for wilate, von Willebrand Factor/Coagulation Factor VIII Complex (Human) Lyophilized Powder for Solution for Intravenous Injection. The approved label now includes routine prophylaxis aimed at reducing the frequency of bleeding episodes in adults and children aged 6 and older with any type of von Willebrand disease (VWD), the most prevalent bleeding […]

admin Health 0 2 min read
December 30, 2023

Analyses of Yescarta CAR T-cell therapy support curative potential in patients with non-Hodgkin lymphomas – Kite/Gilead Sciences

Kite, a Gilead Company announced data from follow-up analyses of three studies of Yescarta (axicabtagene ciloleucel) that demonstrate the long-term survival potential for patients living with several sub-types of relapsed or refractory (R/R) non-Hodgkin lymphoma, which were presented at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. This included ZUMA-1 (Abstract #4864) showing that patients with refractory […]

admin Health 0 4 min read
December 29, 2023

FDA approves Trogarzo 90-second intravenous (IV) push loading dose for the treatment of HIV infection – Theratechnologies Inc

Theratechnologies Inc. announced that the FDA has approved the company’s Labelling Prior Approval Supplement to include a 2000-mg intravenous (IV) push loading dose for Trogarzo (ibalizumab-uiyk). IV push is a method by which the undiluted medication is “pushed” by syringe for faster administration into the body’s circulation and is designed to make Trogarzo administration easier and more convenient for people […]

admin Health 0 1 min read
December 28, 2023

Complete Response Letter for gefapixant, an investigational, non-narcotic, oral selective P2X3 receptor antagonist, under development for the treatment of refractory chronic cough – Merck

Merck Inc., known as MSD outside of the United States and Canada, announced that the FDA has issued a Complete Response Letter (CRL) regarding Merck’s New Drug Application (NDA) for gefapixant, an investigational, non-narcotic, oral selective P2X3 receptor antagonist, under development for the treatment of refractory chronic cough (RCC) or unexplained chronic cough (UCC) in adults . In the CRL, […]

admin Health 0 48 sec read
December 24, 2023

Predicting prenatal care to improve pregnancy outcomes

Socioeconomic factors, like education and location, can affect access to life-saving prenatal care services. Researchers at Boston Children’s Hospital are taking steps towards implementing strategies that improve access to prenatal care: estimating how many pregnant people attend the recommended number of visits and identifying pregnant people who are at high risk of failing to attend. This could help policymakers allocate resources […]

admin Health 0 1 min read
December 22, 2023

Diabetes drug appears to prevent substantial weight gain in female ex-smokers

Dulaglutide.  a Type 2 diabetes treatment, appears to significantly lower the risk of weight gain among women who have stopped smoking, researchers reported after a secondary analysis of clinical trial data. They published their findings on Dec. 19, 2023 in BMJ Nutrition Prevention & Health. As background, the authors noted, “Women seem to have more difficulty quitting smoking than men. This […]

admin Health 0 1 min read
December 21, 2023

CHMP recommends Velsipity (etrasimod) for the treatment of ulcerative colitis – Pfizer

On 14 December 2023, the Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending the granting of a marketing authorisation for the medicinal product Velsipity, intended for the treatment of ulcerative colitis. The applicant for this medicinal product is Pfizer Europe. Velsipity will be available as a 2 mg film-coated tablet. The active substance of Velsipity […]

admin Health 0 49 sec read

Recent Posts

Meta

Categories

Archives

Recent Comments